Last week, a report published by the National Academy of Sciences reviewed 10,000 scientific abstracts on medical marijuana and urged the Drug Enforcement Administration (DEA) to reclassify the drug in order for scientists to study it more easily.
The committee found evidence to support therapeutic uses of cannabis to treat chronic pain in adults. For adults with multiple sclerosis-related muscle spasms, they said there was substantial evidence that short-term use of certain oral cannabinoids improved symptoms. They also found that cannabinoids helped adults with chemotherapy induced nausea and vomiting.
The committee covered a wide range of medical situations in some cases noted there was moderate evidence that cannabis was effective for improving short-term sleep outcomes in individuals with sleep apnea, fibromyalgia, chronic pain and MS.
Get the whole story at www.forbes.com